<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "abciximab inj VIAL">
<dose><value>0.25</value>
<value>0.125</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>2 mg/mL</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction><value>Administer direct over 1 minute. </value>
<value>Administer by continuous infusion for 12 hours.</value>
</instruction>
<volume><value>5 mL</value>
</volume>
<units><value>mg/kg</value>
<value>mcg/kg/minute</value>
</units>
<Population><value>INFANT / CHILDREN</value>
<value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Acute or Subacute Kawasaki Disease.</value>
<value>Unstable Angina, Percutaneous Coronary Intervention (PCI).</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=1572</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antithrombotic Agents, Platelet-Aggregation Inhibitors</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>